Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-07-25

FDA Approved: ATORVASTATIN CALCIUM — Supplemental Application (Quallent)

View source ↗

Summary

FDA approved a supplemental application for atorvastatin calcium from Quallent, indicating a new approval-related action for this generic statin product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ATORVASTATIN CALCIUM (atorvastatin calcium)

Snippet

SUPPL AP for ATORVASTATIN CALCIUM (ATORVASTATIN CALCIUM)